Affinia Therapeutics Secures $40 Million to Advance First-in-Class Gene Therapy for Rare Heart Disease Read more
Datroway Becomes First Therapy to Improve Survival Over Chemotherapy in Hard-to-Treat Triple-Negative Breast Cancer Read more
Chiesi Group and Arbor Biotechnologies Partner to Advance Gene Editing Therapies for Rare Liver Diseases Read more
FDA Lifts Clinical Hold on Neurizon Therapeutics’ ALS Drug NUZ-001, Clearing Path for Phase 2/3 Trial Read more
FDA Approves Roche’s Tecentriq and Lurbinectedin Combo as First Maintenance Therapy for Advanced Small Cell Lung Cancer Read more
FDA Grants Fast Track Designation to Bristol Myers Squibb’s Alzheimer’s Antibody BMS-986446 Read more